NCT06763991

Brief Summary

Eligible patients will be admitted from the outpatient clinic to complete the relevant examinations after admission(Preoperative routine examination and chest CT). The baseline parameters will be registered when admitted to hospital, including case number, diagnosis, sex, age, height, weight, and underlying medical conditions. Patients have at least 12 hours to consider participation in the study and will be given the opportunity to ask questions about the study. Written informed consent will be obtained by the surgical resident or the surgeon after admission to the hospital. Randomization will be done by relevant member . After inclusion, patients will be allocated to one of the two study groups (First-stage Connection or Second-stage Connection) using an online randomization program. The perioperative care will be the same for all included patients.Surgery will be performed by experienced surgeons, with non-expanded ear reconstruction using autologous rib cartilage. The surgery normally comprises two stages. After each surgery, details and duration of the surgery will be documented. For each stage of surgery, patients are scheduled for visits about 3-6 months. In addition, after the total surgery, patients are to fill out 'Glasgow Benefit Inventory' and 'Patient and Observer Scar Assessment Scale'.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P50-P75 for not_applicable

Timeline
10mo left

Started Jun 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress54%
Jun 2025Feb 2027

First Submitted

Initial submission to the registry

January 3, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 8, 2025

Completed
5 months until next milestone

Study Start

First participant enrolled

June 1, 2025

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 20, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 20, 2027

Last Updated

May 16, 2025

Status Verified

May 1, 2025

Enrollment Period

1.7 years

First QC Date

January 3, 2025

Last Update Submit

May 15, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Grade-A healing

    Grade-A healing is defined as optimal wound alignment, epidermal integrity, and tight subcutaneous tissue junctions, with no significant inflammatory response or complications during recovery, and the stitches can be removed within 10 days after the operation.

    For each stage of surgery, patients are scheduled for visits about 3-6 months.

Secondary Outcomes (3)

  • complication rates

    For each stage of surgery, patients are scheduled for visits about 3-6 months.

  • Scar score

    3-6 months after the total ear reconstruction surgery

  • Patients' satisfaction score

    3-6 months after the total ear reconstruction surgery

Study Arms (2)

First-stage Connection

ACTIVE COMPARATOR

After obtaining written informed consent, eligible patients will be randomized with a 1:1 allocation using an online randomization module. A random number will be assigned sequentially to make sure that every patient will be randomly allocated into two groups (Accepting First-stage Connection and Second-stage Connection).

Procedure: One-stage connection

Two-stage connection

EXPERIMENTAL

After obtaining written informed consent, eligible patients will be randomized with a 1:1 allocation using an online randomization module. A random number will be assigned sequentially to make sure that every patient will be randomly allocated into two groups (Accepting One-stage connection and Two-stage connection).

Procedure: Two-stage connection

Interventions

Two-stage connection refers to a procedure that connecting and incorporating the cartilage framework with the residual ear during the second stage surgery of ear reconstruction. An intact cartilage framework is embedded in skin pocket in the first stage, hence, in the second stage of surgery, parts of the cartilage framework that has already survived will be shaved off to ensure the firm combination between the residual era cartilage and grafted costal cartilage.

Two-stage connection

One-stage connection refers to a procedure that connecting and incorporating the cartilage framework with the residual ear in the first stage surgery of ear reconstruction. In one-stage surgery, the cartilage framework is connected with the residual ear (non-deformed, unexcluded part) to form a smooth and complete ear subunit structure. In this way, it is necessary to trim the excess postauricular skin, which may pose a greater risk of blood supply. After the first stage of surgery, the overall appearance of surgical ear is already roughly similar to that of a normal ear.

First-stage Connection

Eligibility Criteria

Age6 Years - 30 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • All consecutive patients between 6 and 30 years with a congenital concha-microtia8, admitted to our hospital are potentially eligible, and enrollment in the study will be based on the following criteria.
  • Patients were fully informed about the purpose, modalities and risks associated with this study, signed an informed consent form and were willing to be followed up.
  • Contrast-enhanced computed tomography (CT) scan shows he or she has 3.Patients can tolerate general anesthesia without severe chronic organic or mental illness.

You may not qualify if:

  • Patients combined with other ear diseases such as ear fistula, titis media, etc.
  • Patients receive other unrelated ear surgeries during the study
  • Skin in the surgical area with infection, ulceration, and scarring.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sichuan provincial people's hospital

Chengdu, Sichuan, 610000, China

Location

Related Publications (1)

  • Zhang X, Chen Z, Chen M, Wang Y, Du L, Cai Z, Jiang Z. Safety and efficacy of connecting the residual ear to the cartilage scaffold in the first-stage versus second-stage surgery: a protocol of a randomised controlled trial in non-expanded auricular reconstruction for concha-type microtia. BMJ Open. 2026 Feb 4;16(2):e104106. doi: 10.1136/bmjopen-2025-104106.

MeSH Terms

Conditions

Congenital Microtia

Condition Hierarchy (Ancestors)

Ear DiseasesOtorhinolaryngologic DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

January 3, 2025

First Posted

January 8, 2025

Study Start

June 1, 2025

Primary Completion (Estimated)

February 20, 2027

Study Completion (Estimated)

February 20, 2027

Last Updated

May 16, 2025

Record last verified: 2025-05

Locations